Using a minimum valuable product and process approach would make it is possible to discipline and structure the development of biopharmaceuticals in the fastest way possible.
There is growing pressure for robust and economically scalable viral-vector manufacturing technologies.
There is growing pressure for robust and economically scalable viral-vector manufacturing technologies.
A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.
Effective cleaning and disinfection along with contamination controls are imperative when operating and utilizing a cleanroom.
The paper reviews a new 24-well filter plate that clarifies and sterile filters high-density cells in one step in minutes. Its depth filter efficiently clarifies cells while a dual-layer membrane provides high-performance sterile filtration
The panel highlights the need for continued research, collaboration between stakeholders, and a strategic approach to leveraging mRNA's capabilities to address unmet clinical needs.
This case study describes how the risk assessment of the first-to-market single-use disc-stack centrifuge was conducted.
The Hatch Waxman safe harbor provision exempts otherwise infringing uses of patented materials if they are in furtherance of a regulatory submission, but the use of patented research tools may fall outside its protection.
Use of a small-scale filler can result in increased filling efficiency.
In this article, the authors explored the elimination of a water rinse and blow down following the caustic wash step, examining potential safety considerations, the effect on the quality of the cleaning process, and the potential benefit of implementing this change.
Now supplying cleanroom doors, panels and accessories for all cleanroom applications.
Gene therapy products present a unique set of challenges for the control of host cell protein impurities.
Establishing analytical workflows for complex biopharmaceutical molecules can help predict their risk of degradation.
The seasonal influenza vaccine market is projected to reach more than $4 Billion USD by the end of 2022. It is a safe assumption that as demand for seasonal influenza vaccines increases, so too with the demand for contract manufacturing organizations (CMOs) to support.
Precise temperature control has a significant influence on performance and quality in chemical process engineering. The Unistat range of temperature control systems ensure accurate temperatures and stable process conditions in research laboratories, pilot plants and kilolabs worldwide.
AFI representatives of the process validation working group explore and define key elements for an enhanced approach to process validation for sterile liquid and freeze-dried forms.
Partnering with a CDMO with collective insights and capabilities to support the development and manufacture of an innovative biotherapeutic program is an essential first step to providing better care to patients.
FLEX2—16-test cell culture analyzer with chemistries, gases, cdv, and osmolality; automated sampling; and refrigerated retains.
A coating technology for a staked needle prefillable syringe reduces the potential risks associated with silicone oil as a lubricant.
As interest in cell and gene therapies continues to grow, the need for safe and consistent reagents to support research, development, and manufacture efforts also increases.
The design of viral clearance studies must keep pace with the quickly evolving biologic drugs industry.
By understanding potential material change, the impact on patient safety can be understood and mitigated.
Extrapolating data from adult clinical trials to a pediatric population is a proven method to avoid unnecessary pediatric clinical trials. Representatives of the Pediatric Working Group of the IQ Consortium share case studies that demonstrate how adult clinical trial data can be used to support the dose selection and regimen—or waive the need for a placebo control arm—for pediatric studies.
The IQ Working Group has defined a pragmatic risk-based approach to audit trail review, where it is only required for high impact GxP data.
Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.
When considering whether to outsource work to a CRO, there are a number of factors to assess, including the type of work that may be outsourced, regulatory considerations, and needs for the study.